Bulletin
Investor Alert

New York Markets Close in:

April 18, 2021, 11:41 p.m. EDT

Methotrexate Drug Market Development and Growth Forecast to 2028

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Amneal Pharmaceuticals Inc. (AMRX)
  • X
    Pfizer Inc. (PFE)
  • X
    Endo International PLC (ENDP)

or Cancel Already have a watchlist? Log In

Apr 18, 2021 (AmericaNewsHour) -- Research Nester published a report titled "Methotrexate Drug Market: Global Demand Analysis & Opportunity Outlook 2028" which delivers a detailed overview of the Methotrexate Drug market in terms of market segmentation by type, by route of administration, by application, by end-users, by distribution channel, and region.

Methotrexate is an FDA approved drug used for treating diseases such as cancer, autoimmune illnesses, ectopic pregnancy, and others. It's widely preferred as a chemotherapy agent owing to its less harmful properties. The rising numbers of patients concerned with the above-mentioned diseases are contributing majorly towards the drug's market growth.

The methotrexate drug marketis projected to witness an achievable high CAGR during the forecast period, i.e., 2020-2028. The market is segmented by type, route of administration, application, end-users, distribution channel, and region. Among distribution channel segmentation ,the hospital pharmacies segment is anticipated to expand significantly during the forecast period owing to growing numbers of target disease patients globally.

Regionally, the methotrexate drug market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region.

The methotrexate drug market in the North-America region is expected to hold a dominant market share on account of the growing occurrence of chronic diseases such as cancer,large-scale investments for refining medical amenities and healthcare sector. Additionally, the growing awareness regarding the target ailments, leading to various campaigns and social media groups, will also steer the growth in the forecast period.

Request Sample of This Strategic Report @ https://www.researchnester.com/sample-request-2738

The European region is anticipated to hold the second-largest market share in the methotrexate drug market after North America on account of rising government spending on healthcare facilities in the region.

The Asia-Pacific region is estimated to witness the fastest growth during the forecast period owing to the growing demand for methotrexate drugin the emerging markets, expansion in healthcare expenditure, infiltration of leading companies into the market, ever-growing population, and an upsurge in disposable income.

The market in Latin America and the Middle East and Africa is anticipated to hit scalable heights in the next few years on account of sincere efforts made by the governments of these regions to encourage the use of medications and spread the awareness about the health disorders.

The rise in the prevalence of target diseases globally is expected to drive the market growth.

A rising number of patient pool diagnosed with cancer, autoimmune diseases, ectopic pregnancy, and medical abortions are contributing significantly towards the overall market growth as they nurture a growing consumption of the drug.

Additionally, a rise in disposable earnings, a surge in healthcare overheads in developing economies, initiatives by various government and private organizations to spread awarenessrelated tocancer and cancer survivors, and awareness formethotrexate drug treatment therapies is likely to drive the market.

Request a Sample Copy of Concerned Market Report @  https://www.researchnester.com/sample-request-2738

This report also provides the existing competitive scenario of some of the key players of the methotrexate drug market which includes company profiling of Apotex Inc., Amneal Pharmaceuticals LLC. /zigman2/quotes/209301288/composite AMRX -3.03% , Teva Pharmaceutical Industries Ltd. (tlv:TEVA), Pfizer Inc. /zigman2/quotes/202877789/composite PFE -0.08% , Silvergate Pharmaceuticals, Inc., Par Pharmaceutical /zigman2/quotes/207745412/composite ENDP +3.87% , Hikma Pharmaceuticals PLC, LingNan Pharmaceutical, Sichuan Huiyu Pharmaceutical Co. Ltd, and Get Well Oncology Pvt Ltd.

About Research Nester

Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights, and industry analysis to help industries, conglomerates, and executives to take wise decisions for their future marketing strategy, expansion and investment, etc. We believe every business can expand to its new horizon, provided the right guidance at the right time is available through strategic minds. Our out of box thinking helps our clients to take wise decisions to avoid future uncertainties.

Contact Us

AJ Daniel
Email:  info@researchnester.com
U.S. Phone: [+1 646 586 9123]
U.K. Phone: [+44 203 608 591]

The post Methotrexate Drug Market Development and Growth Forecast to 2028 appeared first on America News Hour .

COMTEX_384659684/2606/2021-04-18T23:41:24

Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

/zigman2/quotes/209301288/composite
US : U.S.: NYSE
$ 5.61
-0.17 -3.03%
Volume: 722,049
May 7, 2021 11:57a
P/E Ratio
9.06
Dividend Yield
N/A
Market Cap
$1.74 billion
Rev. per Employee
$332,087
loading...
/zigman2/quotes/202877789/composite
US : U.S.: NYSE
$ 39.16
-0.03 -0.08%
Volume: 15.24M
May 7, 2021 11:56a
P/E Ratio
22.92
Dividend Yield
3.98%
Market Cap
$218.61 billion
Rev. per Employee
$533,860
loading...
/zigman2/quotes/207745412/composite
US : U.S.: Nasdaq
$ 5.64
+0.21 +3.87%
Volume: 2.01M
May 7, 2021 11:56a
P/E Ratio
7.21
Dividend Yield
N/A
Market Cap
$1.27 billion
Rev. per Employee
$854,599
loading...

This Story has 0 Comments
Be the first to comment

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.